과제정보
연구 과제 주관 기관 : Ministry of Health, Welfare and Family Affairs
참고문헌
- Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-156. https://doi.org/10.1002/ijc.1440
- El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750. https://doi.org/10.1056/NEJM199903113401001
- Bruix J, Sherman M, Llovet JM, et al. Conclusions of the Barcelona-2000 EASL conference: European Association for the Study of the Liver. J Hepatol 2001;35:421-430. https://doi.org/10.1016/S0168-8278(01)00130-1
- Lencioni RA, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003;228:235-240. https://doi.org/10.1148/radiol.2281020718
- Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology 2004;127:1714-1723. https://doi.org/10.1053/j.gastro.2004.09.003
- Kagawa T, Koizumi J, Kojima S, et al. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection. Cancer 2010;116:3638-3644. https://doi.org/10.1002/cncr.25142
- Choi D, Lim HK, Rhim H, et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 2007;17:684-692. https://doi.org/10.1007/s00330-006-0461-5
- Livraghi T, Meloni F, Di Stasi M, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology 2008;47:82-89.
- N'Kontchou G, Mahamoudi A, Aout M, et al. Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 2009;50:1475-1483. https://doi.org/10.1002/hep.23181
- Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020-1022. https://doi.org/10.1002/hep.24199
- Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003;37:429-442. https://doi.org/10.1053/jhep.2003.50047
- Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999;210:655-661. https://doi.org/10.1148/radiology.210.3.r99fe40655
- McGhana JP, Dodd GD 3rd. Radiofrequency ablation of the liver: current status. AJR Am J Roentgenol 2001;176:3-16. https://doi.org/10.2214/ajr.176.1.1760003
- Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000;214:761-768. https://doi.org/10.1148/radiology.214.3.r00mr02761
- Dupuy DE, Goldberg SN. Image-guided radiofrequency tumor ablation: challenges and opportunities: part II. J Vasc Interv Radiol 2001;12:1135-1148. https://doi.org/10.1016/S1051-0443(07)61670-4
- Curley SA. Radiofrequency ablation of malignant liver tumors. Ann Surg Oncol 2003;10:338-347. https://doi.org/10.1245/ASO.2003.07.017
- Llovet JM, Di Bisceglie AM, Bruix J, et al. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 2008;100:698-711. https://doi.org/10.1093/jnci/djn134
- Bruix J, Sala M, Llovet JM. Chemoembolization for hepatocellular carcinoma. Gastroenterology 2004;127(5 Suppl 1):S179-S188. https://doi.org/10.1053/j.gastro.2004.09.032
- Lencioni R. Loco-regional treatment of hepatocellular carcinoma. Hepatology 2010;52:762-773. https://doi.org/10.1002/hep.23725
- Golfieri R, Cappelli A, Cucchetti A, et al. Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas. Hepatology 2011;53:1580-1589. https://doi.org/10.1002/hep.24246
- Akamatsu M, Yoshida H, Obi S, et al. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial. Liver Int 2004;24:625-629. https://doi.org/10.1111/j.1478-3231.2004.0963.x
- Marelli L, Stigliano R, Triantos C, et al. Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Cancer Treat Rev 2006;32:594-606. https://doi.org/10.1016/j.ctrv.2006.08.002
- Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 2010;30:52-60. https://doi.org/10.1055/s-0030-1247132
- D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17:2265-2281. https://doi.org/10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B
- Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000;11:550-560. https://doi.org/10.1097/00001648-200009000-00011
- Sohn MH, Jeong YJ, Jeong HJ, et al. F-18 FDG PET/CT findings of huge cholesterol granuloma in multiple ribs. Clin Nucl Med 2011;36:942-944. https://doi.org/10.1097/RLU.0b013e31821a2778
- Ravaioli M, Grazi GL, Piscaglia F, et al. Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria. Am J Transplant 2008;8:2547-2557. https://doi.org/10.1111/j.1600-6143.2008.02409.x
- Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006;243:321-328. https://doi.org/10.1097/01.sla.0000201480.65519.b8
- Pompili M, Mirante VG, Rondinara G, et al. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transpl 2005;11:1117-1126. https://doi.org/10.1002/lt.20469
- Hsu CY, Huang YH, Chiou YY, et al. Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: a propensity score analysis. Liver Transpl 2011;17:556-566. https://doi.org/10.1002/lt.22273
- Camma C, Di Marco V, Orlando A, et al. Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study. J Hepatol 2005;42:535-540. https://doi.org/10.1016/j.jhep.2004.11.042
- Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1000 cases. Cancer 2005;103:1201-1209. https://doi.org/10.1002/cncr.20892
- Ng KK, Poon RT, Lo CM, Yuen J, Tso WK, Fan ST. Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma. J Gastrointest Surg 2008;12:183-191. ------------------- https://doi.org/10.1007/s11605-007-0276-y
피인용 문헌
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update vol.11, pp.4, 2017, https://doi.org/10.1007/s12072-017-9799-9
- Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma vol.8, pp.2, 2016, https://doi.org/10.18632/oncotarget.13813
- Comparison of Combined Therapy Using Conventional Chemoembolization and Radiofrequency Ablation Versus Conventional Chemoembolization for Ultrasound-Invisible Early-Stage Hepatocellular Carcinoma (Bar vol.19, pp.6, 2016, https://doi.org/10.3348/kjr.2018.19.6.1130
- Efficacy and Safety of Combined Radiofrequency Ablation with Transarterial Chemoembolization in Patients with Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma Ineligible for Curative Tre vol.73, pp.3, 2019, https://doi.org/10.4166/kjg.2019.73.3.167
- Early experience of combination therapy of transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma measuring 3–7 cm vol.29, pp.1, 2016, https://doi.org/10.4103/ijri.ijri_352_18
- Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of vol.19, pp.1, 2016, https://doi.org/10.1186/s12885-019-6237-5
- Simultaneous transarterial chemoembolization and radiofrequency ablation for large hepatocellular carcinoma vol.12, pp.1, 2016, https://doi.org/10.4251/wjgo.v12.i1.92
- Efficacy and Safety of the Radiotherapy for Liver Cancer: Assessment of Local Controllability and Its Role in Multidisciplinary Therapy vol.12, pp.10, 2020, https://doi.org/10.3390/cancers12102955
- The clinical effects of ultrasound-guided microwave ablation in the treatment of primary hepatic carcinoma : Protocol for a retrospective clinical observation vol.100, pp.48, 2016, https://doi.org/10.1097/md.0000000000028045
- Hyperthermia ablation combined with transarterial chemoembolization versus monotherapy for hepatocellular carcinoma: A systematic review and meta‐analysis vol.10, pp.23, 2021, https://doi.org/10.1002/cam4.4350
- Image-guided microwave ablation of hepatocellular carcinoma (≤5.0 cm): is MR guidance more effective than CT guidance? vol.21, pp.1, 2021, https://doi.org/10.1186/s12885-021-08099-7
- Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysis vol.19, pp.1, 2016, https://doi.org/10.1186/s12957-021-02188-4
- Combined treatments in hepatocellular carcinoma: Time to put them in the guidelines? vol.13, pp.12, 2016, https://doi.org/10.4251/wjgo.v13.i12.1896
- Long-term outcomes of combined transarterial chemoembolization and radiofrequency ablation versus RFA monotherapy for single hepatocellular carcinoma ≤3 cm: emphasis on local tumor progression vol.39, pp.1, 2016, https://doi.org/10.1080/02656736.2021.1998660